{"id":"W2104504726","doi":"10.1200/jco.2007.13.9030","title":"Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2670,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"American Society of Clinical Oncology; Les Laboratories Pierre Fabre; Sanofi; GlaxoSmithKline; Eli Lilly and Company","keywords":"Medicine; Vinorelbine; Internal medicine; Vinca; Chemotherapy; Etoposide; Hazard ratio; Vinca alkaloid; Cisplatin; Lung cancer; Oncology; Stage (stratigraphy); Vindesine; Clinical trial; Confidence interval; Pharmacology; Cyclophosphamide; Vincristine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}